ENGINEERING MEDICINES TO IMPROVE PATIENT CARE Investors News Releases Year None2022202120202019201820172016 August 8, 2022 Viridian Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call on August 15, 2022 August 5, 2022 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 8, 2022 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 23, 2022 Viridian Therapeutics Appoints Carrie Melvin as Chief Operating Officer June 3, 2022 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 1, 2022 Viridian Therapeutics to Participate in June Investor Conferences May 12, 2022 Viridian Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates May 3, 2022 Viridian Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 12, 2022 April 6, 2022 Viridian Therapeutics to Participate in The 21st Annual Needham Virtual Healthcare Conference on April 14 April 4, 2022 Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules Capital Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 17
Year None2022202120202019201820172016 August 8, 2022 Viridian Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call on August 15, 2022 August 5, 2022 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) July 8, 2022 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 23, 2022 Viridian Therapeutics Appoints Carrie Melvin as Chief Operating Officer June 3, 2022 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) June 1, 2022 Viridian Therapeutics to Participate in June Investor Conferences May 12, 2022 Viridian Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates May 3, 2022 Viridian Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 12, 2022 April 6, 2022 Viridian Therapeutics to Participate in The 21st Annual Needham Virtual Healthcare Conference on April 14 April 4, 2022 Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules Capital Current page 1 Page 2 Next page next › Last page last » Displaying 1 - 10 of 17
August 8, 2022 Viridian Therapeutics to Report Second Quarter 2022 Financial Results and Host Conference Call on August 15, 2022
August 5, 2022 Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 12, 2022 Viridian Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates
May 3, 2022 Viridian Therapeutics to Report First Quarter 2022 Financial Results and Host Conference Call on May 12, 2022
April 6, 2022 Viridian Therapeutics to Participate in The 21st Annual Needham Virtual Healthcare Conference on April 14
April 4, 2022 Viridian Therapeutics Secures Flexible Credit Facility for Up to $75 Million From Hercules Capital